French Industry Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Industry Network.

Press releases published on September 9, 2026

Sep. 9, 2026

Recruiting for Good Launches Luxury Travel Reward ‘2027 Paris Parties’

Indeterminate EIN Presswire

Sep. 9, 2026

Proxima Fusion and Lower Saxony sign MoU to build Europe’s first large-scale fusion-grade HTS tape facility

Indeterminate EIN Presswire

Sep. 9, 2026

Choroideremia Research Foundation Announces New Research Grants to Advance Understanding and Treatment of CHM

Indeterminate EIN Presswire

Sep. 9, 2026

TAIMATSU Opens Oysters & Sushi -ITTO- in Hiroshima

Indeterminate EIN Presswire

Sep. 9, 2026

Inprentus Delivers Highly Curved, Concave Diffraction Gratings for NASA Solar Science Mission

Indeterminate EIN Presswire

Sep. 9, 2026

Quantum's Value in AI Supercomputing Will Be Decided by the Full Stack, Not Qubits Alone, Find Alice & Bob and Hyperion

Indeterminate EIN Presswire

Sep. 9, 2026

Create Energy Subsidiary SOL Components Secures U.S. Patent for Innovative QuickGrip™ Solar Mounting Technology

Indeterminate EIN Presswire

Sep. 9, 2026

NANOBIOTIX to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 9, 2026

NANOBIOTIX Participera à la Conférence H.C. Wainwright 28th Annual Global Investment

Indeterminate GlobeNewswire

Sep. 9, 2026

D.D. MEC Releases Francophone Album 'À Ma Façon' With Seven Music Videos

Indeterminate EIN Presswire

Sep. 9, 2026

SAYELA Releases 'Say My Name Slow' Across Global Streaming Platforms

Indeterminate EIN Presswire

Sep. 9, 2026

XS.com remporte les prix « Meilleur courtier mondial » et « Meilleure expérience de trading » à Casablanca

Indeterminate EIN Presswire

Sep. 9, 2026

OSE Immunotherapeutics Welcomes First Patient Dosed by Veloxis in the Phase 2 RENGEVITY-201 Trial Evaluating Pegrizeprument (VEL-101) for the Prevention of Organ Rejection in Kidney Transplant Recipients

Indeterminate GlobeNewswire

Sep. 9, 2026

OSE Immunotherapeutics se félicite de l’inclusion du premier patient traité par Veloxis dans l’étude de phase 2 RENGEVITY-201 évaluant le pegrizeprument (VEL-101) dans la prévention du rejet d’organe chez les patients transplantés rénaux

Indeterminate GlobeNewswire

Sep. 9, 2026

Esker Introduces the Synergy Agentic Framework for the Office of the CFO

Indeterminate GlobeNewswire

Sep. 9, 2026

A Syngenta e a Amoéba concluíram um acordo de distribuição exclusivo na Europa para oferecer aos produtores de cereais uma inovação biofungicida

Indeterminate GlobeNewswire

Sep. 9, 2026

newcleo Appoints Nuclear Industry Veteran Jeffrey Lyash as Chairman of the Board

Indeterminate GlobeNewswire

Sep. 9, 2026

Dassault Aviation : Réception des deux premiers Falcon Albatros par la DGA

Indeterminate GlobeNewswire

Sep. 9, 2026

Dassault Aviation: Reception of the First Two Falcon Albatros Aircraft by the DGA

Indeterminate GlobeNewswire

Sep. 9, 2026

Syngenta et Amoéba ont conclu un accord de distribution exclusif en Europe pour proposer aux céréaliers une innovation biofongicide

Indeterminate GlobeNewswire